(BRBR) Bellring Brands - Ratings and Ratios
Protein Shakes, Nutrition Bars, Protein Powders, RTD Beverages
BRBR EPS (Earnings per Share)
BRBR Revenue
Description: BRBR Bellring Brands
BellRing Brands LLC (NYSE:BRBR) is a leading provider of nutrition products in the United States, operating primarily under the Premier Protein and Dymatize brands. The company offers a diverse range of products, including ready-to-drink protein shakes, other RTD beverages, protein powders, and nutrition bars, catering to the growing demand for health and wellness products.
From a market perspective, BellRing Brands has a significant presence across various distribution channels, including club, food, drug, mass, eCommerce, specialty, and convenience stores. This broad reach enables the company to tap into different customer segments and capitalize on emerging trends in the nutrition industry. With a market capitalization of approximately $7.4 billion, BRBR is a notable player in the Personal Care Products sub-industry.
To further analyze BRBRs performance, key performance indicators (KPIs) such as revenue growth, gross margin, and operating expenses as a percentage of revenue can be examined. For instance, a high revenue growth rate could indicate the companys ability to expand its customer base and increase sales. Additionally, metrics like return on equity (ROE) and return on assets (ROA) can provide insights into the companys profitability and asset utilization efficiency. Although the provided ROE of -132.27% suggests potential issues with profitability, further investigation is needed to understand the underlying causes.
From a valuation perspective, BRBRs price-to-earnings (P/E) ratio of 27.20 and forward P/E of 23.09 can be compared to industry averages to determine if the stock is overvalued or undervalued. Other relevant metrics, such as the dividend yield, enterprise value-to-EBITDA (EV/EBITDA), and price-to-book (P/B) ratio, can also be analyzed to gain a more comprehensive understanding of the companys valuation.
BRBR Stock Overview
| Market Cap in USD | 4,833m |
| Sub-Industry | Personal Care Products |
| IPO / Inception | 2019-10-17 |
BRBR Stock Ratings
| Growth Rating | 26.2% |
| Fundamental | 67.9% |
| Dividend Rating | - |
| Return 12m vs S&P 500 | -36.6% |
| Analyst Rating | 4.35 of 5 |
BRBR Dividends
Currently no dividends paidBRBR Growth Ratios
| Growth Correlation 3m | -92.8% |
| Growth Correlation 12m | -38.1% |
| Growth Correlation 5y | 86.6% |
| CAGR 5y | 16.19% |
| CAGR/Max DD 5y | 0.30 |
| Sharpe Ratio 12m | 1.05 |
| Alpha | -41.22 |
| Beta | 0.846 |
| Volatility | 75.02% |
| Current Volume | 3506.2k |
| Average Volume 20d | 3356.6k |
| Stop Loss | 39.4 (-4%) |
| Signal | 0.89 |
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income (228.3m TTM) > 0 and > 6% of Revenue (6% = 133.5m TTM) |
| FCFTA 0.13 (>2.0%) and ΔFCFTA -17.47pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 20.19% (prev 18.10%; Δ 2.08pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.13 (>3.0%) and CFO 131.6m <= Net Income 228.3m (YES >=105%, WARN >=100%) |
| Net Debt (965.3m) to EBITDA (255.2m) ratio: 3.78 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.55 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (129.7m) change vs 12m ago -1.82% (target <= -2.0% for YES) |
| Gross Margin 35.43% (prev 34.15%; Δ 1.28pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 247.4% (prev 237.9%; Δ 9.53pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 4.0 (EBITDA TTM 255.2m / Interest Expense TTM 63.8m) >= 6 (WARN >= 3) |
Altman Z'' 5.74
| (A) 0.45 = (Total Current Assets 739.4m - Total Current Liabilities 290.4m) / Total Assets 993.7m |
| (B) 0.21 = Retained Earnings (Balance) 213.0m / Total Assets 993.7m |
| (C) 0.28 = EBIT TTM 255.2m / Avg Total Assets 898.9m |
| (D) 0.16 = Book Value of Equity 213.5m / Total Liabilities 1.30b |
| Total Rating: 5.74 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 67.89
| 1. Piotroski 5.0pt = 0.0 |
| 2. FCF Yield 2.08% = 1.04 |
| 3. FCF Margin 5.70% = 1.42 |
| 4. Debt/Equity data missing |
| 5. Debt/Ebitda 5.09 = -2.50 |
| 6. ROIC - WACC 20.74% = 12.50 |
| 7. RoE data missing |
| 8. Rev. Trend 94.14% = 4.71 |
| 9. Rev. CAGR 14.29% = 1.79 |
| 10. EPS Trend 28.84% = 0.72 |
| 11. EPS CAGR -14.31% = -1.79 |
What is the price of BRBR shares?
Over the past week, the price has changed by +2.86%, over one month by -26.47%, over three months by -33.48% and over the past year by -25.88%.
Is Bellring Brands a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of BRBR is around 36.83 USD . This means that BRBR is currently overvalued and has a potential downside of -10.28%.
Is BRBR a buy, sell or hold?
- Strong Buy: 10
- Buy: 3
- Hold: 4
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the BRBR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 58.7 | 43.1% |
| Analysts Target Price | 84.8 | 106.5% |
| ValueRay Target Price | 40.7 | -0.9% |
Last update: 2025-08-18 02:03
BRBR Fundamental Data Overview
CCE Cash And Equivalents = 43.7m USD (Cash And Short Term Investments, last quarter)
P/E Trailing = 21.92
P/E Forward = 16.2338
P/S = 2.1727
Beta = 0.79
Revenue TTM = 2.22b USD
EBIT TTM = 255.2m USD
EBITDA TTM = 255.2m USD
Long Term Debt = 1.01b USD (from longTermDebt, last quarter)
Short Term Debt = 290.4m USD (from totalCurrentLiabilities, last quarter)
Debt = 1.30b USD (Calculated: Short Term 290.4m + Long Term 1.01b)
Net Debt = 965.3m USD (from netDebt column, last quarter)
Enterprise Value = 6.09b USD (4.83b + Debt 1.30b - CCE 43.7m)
Interest Coverage Ratio = 4.0 (Ebit TTM 255.2m / Interest Expense TTM 63.8m)
FCF Yield = 2.08% (FCF TTM 126.7m / Enterprise Value 6.09b)
FCF Margin = 5.70% (FCF TTM 126.7m / Revenue TTM 2.22b)
Net Margin = 10.26% (Net Income TTM 228.3m / Revenue TTM 2.22b)
Gross Margin = 35.43% ((Revenue TTM 2.22b - Cost of Revenue TTM 1.44b) / Revenue TTM)
Tobins Q-Ratio = 28.52 (Enterprise Value 6.09b / Book Value Of Equity 213.5m)
Interest Expense / Debt = 1.42% (Interest Expense 18.4m / Debt 1.30b)
Taxrate = 25.17% (from yearly Income Tax Expense: 82.9m / 329.4m)
NOPAT = 191.0m (EBIT 255.2m * (1 - 25.17%))
Current Ratio = 2.55 (Total Current Assets 739.4m / Total Current Liabilities 290.4m)
Debt / EBITDA = 5.09 (Net Debt 965.3m / EBITDA 255.2m)
Debt / FCF = 10.26 (Debt 1.30b / FCF TTM 126.7m)
Total Stockholder Equity = -229.1m (last 4 quarters mean)
RoA = 22.97% (Net Income 228.3m, Total Assets 993.7m )
RoE = unknown (Net Income TTM 228.3m / Total Stockholder Equity -229.1m)
RoCE = 32.72% (Ebit 255.2m / (Equity -229.1m + L.T.Debt 1.01b))
RoIC = 28.16% (NOPAT 191.0m / Invested Capital 678.2m)
WACC = 7.42% (E(4.83b)/V(6.13b) * Re(9.13%)) + (D(1.30b)/V(6.13b) * Rd(1.42%) * (1-Tc(0.25)))
Shares Correlation 5-Years: 0.0 | Cagr: 34.53%
Discount Rate = 9.13% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 69.73% ; FCFE base≈173.2m ; Y1≈135.3m ; Y5≈87.6m
Fair Price DCF = 10.83 (DCF Value 1.36b / Shares Outstanding 126.0m; 5y FCF grow -26.08% → 3.0% )
Revenue Correlation: 94.14 | Revenue CAGR: 14.29%
Rev Growth-of-Growth: -5.67
EPS Correlation: 28.84 | EPS CAGR: -14.31%
EPS Growth-of-Growth: -47.86
Additional Sources for BRBR Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle